4.6 Article

Anterograde Degeneration along the Visual Pathway after Optic Nerve Injury

期刊

PLOS ONE
卷 7, 期 12, 页码 -

出版社

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0052061

关键词

-

资金

  1. Ophthalmic Research Institute Australia (ORIA)
  2. National Multiple Sclerosis Society (NMSS)
  3. Multiple Sclerosis Research Australia (MSRA Incubator Grant) [10-057]
  4. Macquarie University New Staff (MQNS) Grant
  5. Sydney Foundation for Medical Research
  6. Allergan Australia
  7. Novartis Pharmaceuticals Australia

向作者/读者索取更多资源

Purpose: To investigate anterograde degenerative changes along the visual pathway in a rat model of optic nerve axotomy. Methods: Optic nerve transection was performed in adult Sprague-Dawley rats. Animals were sacrificed at regular time intervals and tissues harvested. Immunoblotting followed by densitometric analysis was used to determine the phosphorylation profile of Akt in the dorsal lateral geniculate nucleus (dLGN) and the primary visual cortex (V1). The neuronal cell size and cell density were measured in the dLGN and the V1 using Nissl staining. The prevalence of apoptosis was characterized by terminal deoxynucleotidyl-transferase-mediated biotin-dUTP nick end labelling (TUNEL) histochemistry. Caspase-3 antibodies were also used to identify apoptotic cells. Neurons and astrocytes were detected using NeuN and glial fibrillary acidic protein (GFAP), respectively. Results: An early and sustained loss of Akt phosphorylation was observed after optic nerve transection in both dLGN and V1. At week one, a decrease in the neuronal cell size (50.5 +/- 4.9 vs 60.3 +/- 5.0 mu m(2), P = 0.042) and an increase of TUNEL positive cells (7.9 +/- 0.6 vs 1.4 +/- 0.56 x 10(2) cells/mm(2), P<0.001) were evident in the dLGN but not in V1. A significant decline in neuronal cell number (14.5 +/- 0.1 vs 17.4 +/- 1.3 x 10(2) cells/mm(2), P = 0.048), cell size (42.5 +/- 4.3 vs 62.1 +/- 4.7 mu m(2), P = 0.001) and an increase in apoptotic cells (5.6 +/- 0.5 vs 2.0 +/- 0.4 x 10(2) cells/mm(2), P<0.001) appeared in V1 initially at one month post-transection. The changes in the visual pathway continued through two months. Both neuronal cells and GFAP-positive glial cells were affected in this anterograde degeneration along the visual pathway. Conclusions: Anterograde degeneration along the visual pathway takes place in target relay (LGN) and visual cortex following the optic nerve injury. Apoptosis was observed in both neural and adjacent glial cells. Reduction of Akt phosphorylation preceded cellular and apoptotic changes.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

Computational refinement identifies functional destructive single nucleotide polymorphisms associated with human retinoid X receptor gene

Soumalya Sarkar, Vivek K. Gupta, Samridhi Sharma, Ting Shen, Veer Gupta, Mehdi Mirzaei, Stuart L. Graham, Nitin Chitranshi

Summary: Alterations in RXR signalling are associated with neurodegenerative disorders. This study identified deleterious SNPs that affect the structure and function of RXR isoforms. Seven missense mutations were found in RXR isoforms, including two novel mutations. In silico prediction tools were used to assess the pathogenicity and stability of RXR mutations. The analysis showed a mix of conclusive and inconclusive genotype-phenotype correlations.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2023)

Article Biochemistry & Molecular Biology

S1PR1 signaling attenuates apoptosis of retinal ganglion cells via modulation of cJun/Bim cascade and Bad phosphorylation in a mouse model of glaucoma

Devaraj Basavarajappa, Vivek Gupta, Roshana Vander Wall, Veer Gupta, Nitin Chitranshi, Seyed Shahab Oddin Mirshahvaladi, Viswanthram Palanivel, Yuyi You, Mehdi Mirzaei, Alexander Klistorner, Stuart L. Graham

Summary: Glaucoma is a complex neurodegenerative disease characterized by optic nerve damage and apoptotic retinal ganglion cell (RGC) death. Our study demonstrated that activation of neuronal S1PR1 with siponimod treatment can exert neuroprotection in glaucoma by upregulating Akt and Erk1/2 activation and suppressing the apoptotic signaling via modulation of the c-Jun/Bim cascade and increasing Bad phosphorylation. Conversely, deletion of S1PR1 in RGCs diminished the neuroprotective effects of siponimod treatment. These findings suggest that S1PR1 is a potential therapeutic target for neuroprotection in glaucoma.

FASEB JOURNAL (2023)

Article Cell Biology

Siponimod exerts neuroprotective effects on the retina and higher visual pathway through neuronal S1PR1 in experimental glaucoma

Devaraj Basavarajappa, Vivek Gupta, Nitin Chitranshi, Roshana Vander Wall, Rashi Rajput, Kanishka Pushpitha, Samridhi Sharma, Mehdi Mirzaei, Alexander Klistorner, Stuart Graham

Summary: The S1PR1 signaling pathway plays a crucial role in the survival of retinal ganglion cells and neurons in the dorsolateral geniculate nucleus. Siponimod, as a modulator of S1PR1, exerts direct neuroprotective effects in neurons in the central nervous system, independent of its peripheral immunomodulatory effects.

NEURAL REGENERATION RESEARCH (2023)

Article Clinical Neurology

Retinal pathological features and proteome signatures of Alzheimer's disease

Yosef Koronyo, Altan Rentsendorj, Nazanin Mirzaei, Giovanna C. Regis, Julia Sheyn, Haoshen Shi, Ernesto Barron, Galen Cook-Wiens, Anthony R. Rodriguez, Rodrigo Medeiros, Joao A. Paulo, Veer B. Gupta, Andrei A. Kramerov, Alexander V. Ljubimov, Jennifer E. Van Eyk, Stuart L. Graham, Vivek K. Gupta, John M. Ringman, David R. Hinton, Carol A. Miller, Keith L. Black, Antonino Cattaneo, Giovanni Meli, Mehdi Mirzaei, Dieu-Trang Fuchs, Maya Koronyo-Hamaoui

Summary: Pathologies of Alzheimer’s disease (AD) can be found in the neurosensory retina, but their exact nature and distribution in relation to disease progression in the brain are still largely unknown. This study conducted extensive histopathological and biochemical investigations of postmortem retina and brain tissues from 86 human donors to better understand the pathological features of AD in the retina. The findings suggest a quantitative relationship between retinopathy, brain pathology, and cognitive impairment, and may lead to the development of reliable retinal biomarkers for noninvasive screening and monitoring of AD.

ACTA NEUROPATHOLOGICA (2023)

Article Clinical Neurology

Retinal arterial Aβ40 deposition is linked with tight junction loss and cerebral amyloid angiopathy in MCI and AD patients

Haoshen Shi, Yosef Koronyo, Dieu-Trang Fuchs, Julia Sheyn, Ousman Jallow, Krishna Mandalia, Stuart L. Graham, Vivek K. Gupta, Mehdi Mirzaei, Andrei A. Kramerov, Alexander V. Ljubimov, Debra Hawes, Carol A. Miller, Keith L. Black, Roxana O. Carare, Maya Koronyo-Hamaoui

Summary: This study found that vascular amyloid beta (Aβ) protein deposits were detected in retinas of mild cognitively impaired (MCI) and Alzheimer's disease (AD) patients, and these deposits were linked to disease status. The study also revealed that the components of retinal vascular tight junctions (TJs) and Aβ expression were correlated with neuropathology. The severe decreases in retinal vascular zonula occludens-1 (ZO-1) and claudin-5 were identified in MCI and AD patients, which correlated with arteriolar Aβ(40) deposition and cerebral pathology and cognitive deficits.

ALZHEIMERS & DEMENTIA (2023)

Article Biotechnology & Applied Microbiology

Neuroserpin gene therapy inhibits retinal ganglion cell apoptosis and promotes functional preservation in glaucoma

Nitin Chitranshi, Rashi Rajput, Angela Godinez, Kanishka Pushpitha, Mehdi Mirzaei, Devaraj Basavarajappa, Veer Gupta, Samridhi Sharma, Yuyi You, Giovanna Galliciotti, Ghasem H. Salekdeh, Mark S. Baker, Stuart L. Graham, Vivek K. Gupta

Summary: Our research shows that oxidation deactivation impairs the inhibitory activity of the serine protease inhibitor neuroserpin (NS) in glaucoma. The loss of NS is detrimental to retinal structure and function, and perturbations in autophagy and microglial and synaptic markers are associated with NS ablation. On the other hand, upregulation of NS promotes retinal ganglion cell (RGC) survival and protects against glaucoma-induced degeneration.

MOLECULAR THERAPY (2023)

Article Cell Biology

Retinal thickness and vascular parameters using optical coherence tomography in Alzheimer's disease: a meta-analysis

Samran Sheriff, Ting Shen, Sandra Abdal, Danit Saks, Mehdi Mirzaei, Veer Gupta, Nitin Chitranshi, Yuyi You, Angela Schultz, Stuart Graham, Vivek Gupta

Summary: Examining retinal tissue provides a unique method to quantify Alzheimer's disease-related changes. This meta-analysis investigated optical coherence tomography parameters and discovered that Alzheimer's disease patients had lower retinal nerve fiber layer thickness and thinner macular parameters compared to controls. Optical coherence tomography angiography parameters showed mixed results between Alzheimer's disease and controls. Overall, our findings suggest that optical coherence tomography technology can detect retinal and microvascular changes in Alzheimer's disease patients and aid in monitoring and early diagnosis.

NEURAL REGENERATION RESEARCH (2023)

Article Neurosciences

Extracellular vesicles as reconfigurable therapeutics for eye diseases: Promises and hurdles

Faezeh Shekari, Morteza Abyadeh, Anna Meyfour, Mehdi Mirzaei, Nitin Chitranshi, Vivek Gupta, Stuart L. Graham, Ghasem Hosseini Salekdeh

Summary: A large number of people around the world suffer from visual impairment, and the available therapies focus on preventing the progression of eye disorders. This review explores the potential of using extracellular vesicles (EVs) as a regenerative therapy for eye-related complications. The review examines the current knowledge about EVs and their therapeutic applications, as well as the challenges in translating EV-based therapy into clinical settings.

PROGRESS IN NEUROBIOLOGY (2023)

Article Biochemistry & Molecular Biology

Oxidative Stress Induced Dysfunction of Protein Synthesis in 661W Mice Photoreceptor Cells

Liting Deng, Vivek Gupta, Morteza Abyadeh, Nitin Chitranshi, Kanishka Pushpitha, Yunqi Wu, Veer Gupta, Yuyi You, Joao A. Paulo, Stuart L. Graham, Mehdi Mirzaei, Paul A. Haynes

Summary: Photoreceptor cells are highly vulnerable to oxidative stress, which plays a key role in ocular diseases leading to retinal degeneration and blindness. A mass-spectrometric study using TMT labelling revealed proteome changes in photoreceptor cells following oxidative stress induction. Differential expression of proteins involved in various pathways was observed in response to oxidative stress, including ECM receptor interaction, oxidative phosphorylation, and spliceosome pathways.

PROTEOMES (2023)

Article Ophthalmology

Genetic risk of glaucoma is associated with vascular and retinal nerve fibre wedge defects

Danit G. Saks, Angela Schulz, Ayub Qassim, Henry Marshall, Alex W. Hewitt, Stuart Macgregor, Jamie E. Craig, Stuart L. Graham

Summary: Individuals with a higher genetic risk of glaucoma are more likely to have retinal vascular defects and structural glaucomatous loss, but this is not related to systemic cardiovascular risk.

ACTA OPHTHALMOLOGICA (2023)

Article Neurosciences

Anti-inflammatory Effects of Siponimod in a Mouse Model of Excitotoxicity-Induced Retinal Injury

Devaraj Basavarajappa, Vivek Gupta, Nitin Chitranshi, Deepa Viswanathan, Veer Gupta, Roshana Vander Wall, Viswanthram Palanivel, Mehdi Mirzaei, Yuyi You, Alexander Klistorner, Stuart L. Graham

Summary: Glaucoma is a major cause of permanent blindness worldwide, characterized by neurodegeneration and neuroinflammation. Siponimod, an immunomodulatory drug, has shown protective effects against acute NMDA excitotoxicity in the retina. Activation of glial cells, inflammatory pathways, and the NLRP3 inflammasome were suppressed with siponimod treatment. These findings suggest that siponimod has anti-inflammatory effects and could be a potential therapeutic strategy for neuroinflammatory conditions.

MOLECULAR NEUROBIOLOGY (2023)

暂无数据